reversed-phase HPLC is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-01-16. Where a claim depends on a specific study, the study is described rather than over-claimed.
Epitalon emerged from research conducted in Saint Petersburg by Vladimir Khavinson and colleagues, who studied short peptides as potential regulators of aging. The work built on epithalamin, a pineal gland extract reported to influence neuroendocrine function. Epitalon was designed as a synthetic counterpart with a defined sequence, allowing reproducible experiments that extracts could not support. Early publications described effects on melatonin rhythms and lifespan in animal models. These findings circulated mainly in Russian-language journals during the 1990s, which limited their visibility among English-speaking researchers.
The most widely cited claim is that epitalon activates telomerase and thereby extends telomere length. Supporting evidence comes largely from cultured human cells, where treatment was associated with increased telomerase activity and delayed replicative senescence. Telomerase activation is a biologically consequential effect, since the enzyme is largely silenced in most somatic cells. However, the route by which a short peptide would reach and act on the enzyme's regulatory machinery has not been established. Independent replication in human trials is scarce, so the link between cell-culture observations and whole-body aging remains an open question.
Human data are limited to small studies, often without the randomization, blinding, or control groups expected in contemporary clinical research. Reported outcomes have included changes in melatonin levels, immune markers, and subjective measures, but sample sizes were generally too small to support firm conclusions. Some reviews treat the peptide as promising while noting methodological weaknesses; others question whether the observed effects are specific. The compound is frequently discussed in longevity-focused communities, where enthusiasm often outpaces the published evidence. Separating established findings from speculation is therefore important when reading summaries of this research.
The molecule is a short, linear, hydrophilic peptide that dissolves readily in water or aqueous buffer. Its principal chemical liabilities are hydrolytic rather than oxidative, since it contains no cysteine, methionine, or tryptophan residues. The aspartate–glycine step is a recognised site for aspartimide formation under mildly acidic or basic conditions, generating isoaspartate and succinimide-related products over time. Desiccated lyophilised powder held at −20 °C is comparatively stable, whereas dilute solutions degrade faster and are best frozen as single-use aliquots rather than thawed repeatedly.
No pharmacopoeial monograph exists for this peptide, so quality rests on the supplier's internal specifications and on whatever independent testing a purchaser arranges. Certificates of analysis differ widely in which tests they report and in the limits applied. The counter-ion introduced during purification, commonly acetate or trifluoroacetate, changes the net peptide content of a given mass of powder, so two samples of equal weight may not contain equal amounts of the active sequence. Third-party laboratories can verify purity, identity, residual solvents, and counter-ion content for a fee, which makes documentation more informative than labelling.
Verification of a sample usually begins with reversed-phase high-performance liquid chromatography, which resolves the peptide from truncated sequences and other impurities and expresses purity as a percentage of total peak area. Mass spectrometry by electrospray ionisation or matrix-assisted laser desorption supplies an independent check, because the measured mass can be compared against the theoretical value for AEDG. Amino acid analysis or tandem mass spectrometry sequencing can confirm residue order. Each of these methods answers a different question: a purity figure does not establish identity, and an identity match does not establish how much of the material is intact peptide.
| Property | Value | Notes |
|---|---|---|
| Peptide sequence | Ala-Glu-Asp-Gly | Single-letter form AEDG |
| Compound class | Synthetic tetrapeptide | Not a natural free peptide |
| Research origin | Russian gerontology institutes | Developed during the 1990s |
| Main research claim | Telomerase activation | Evidence mainly from cultured cells |
| Regulatory status | Not an approved drug | Handled as a research material |
Identity confirmation uses mass spectrometry, usually electrospray ionisation in positive mode or matrix-assisted laser desorption. The protonated free peptide produces a signal near three hundred and ninety-one daltons, while salt adducts shift that value slightly. Tandem mass spectrometry or amino acid analysis supplies sequence-level confirmation, which a single mass measurement cannot. Peptides containing aspartate can cyclise into succinimide intermediates that hydrolyse to isoaspartate isomers of identical mass. Because those isomers are difficult to separate chromatographically, identity and purity results carry more weight when interpreted together.
Storage practice centres on limiting moisture, oxygen, and repeated temperature cycling. Freeze-dried powder is generally held desiccated at minus twenty degrees Celsius or colder and protected from light. Reconstituted solutions are markedly less stable, and the aspartate-glycine junction is prone to succinimide formation at neutral to mildly alkaline pH. Portioning material into single-use aliquots reduces degradation compared with repeated freeze-thaw cycles. Stability data specific to this tetrapeptide remain scarce, so most handling guidance is extrapolated from general peptide chemistry rather than measured directly.
Documentation accompanying research peptides usually includes a certificate of analysis listing the batch number, purity figure, and test methods applied. Buyers comparing suppliers should check whether the reported purity refers to chromatographic area or to a mass-balance calculation, because the two are not equivalent. Counter-ion content, residual solvents, and water content are sometimes omitted from such certificates even though they affect the actual peptide mass present. Independent verification through a second laboratory is the most direct way to confirm that a supplied material matches its label.
Reversed-phase high-performance liquid chromatography is the standard approach for assessing purity, usually with ultraviolet detection near 214 nm, where the peptide bond absorbs. Mass spectrometry, most often with electrospray ionization, confirms the molecular mass and helps reveal truncation or deletion byproducts. Amino acid analysis can verify composition, and counterion content is sometimes measured because peptides purified with trifluoroacetic acid retain variable amounts of that salt. Purity figures reported without a stated method and detection wavelength are difficult to interpret.
Material sold for research use varies widely in documented quality. A useful verification package includes a certificate of analysis that states peptide content rather than only net weight, the chromatographic method and column used, and a mass spectrum consistent with the expected mass. Independent testing by a third-party laboratory is occasionally reported. Statements of identity resting only on a supplier label provide little assurance, and the gap between nominal mass and actual peptide content can be substantial once counterions and residual water are counted.
Peptides of this size are generally stable as dry solids but degrade in solution over time. The principal routes are hydrolysis of the peptide backbone and oxidation, with hydrolysis favoured by elevated temperature and extreme pH. Aqueous solutions held at room temperature can show measurable loss of purity within days, while frozen aliquots are considerably more durable. Because the sequence contains neither cysteine nor methionine, oxidation is less of a concern than for many other peptides, but pH control during handling still matters.
In 1992, whilst studying for his PhD, he also ran the London Marathon, in a time of 4 hours and 41 minutes, to raise money to buy a computer for a young boy with physical disabilities. Skinner's PhD involved developing genetic tests to detect congenital adrenal hyperplasia in children. He had work published in a number of scientific journals. In 1994 he had his work published in Human Molecular Genetics. In 1994, Skinner married Dr. Monica Schneider (also a molecular biologist), and in 1996 their son James was born. From 1994 to 1996 Skinner worked as a Post-Doctoral Research Fellow at Vanderbilt University Medical Center, in Nashville, Tennessee. The work he carried out there involved gene sequencing and protein purification of cytochrome P450 enzymes. His work was published in the Journal of Biological Chemistry. From 1996 to 1997 Skinner took care of his infant son, James, whilst his wife continued to work at Vanderbilt University Medical Center.
The combination of heroin and xylazine produces a potentially more deadly high than heroin alone. Xylazine is also frequently found in "speedball", a mixture of a stimulant drug such as cocaine with a depressant drug such as heroin, morphine and/or fentanyl. As of 2012, causal factors underlying xylazine's increasing popularity were still unknown. As of 2022, more information on the distribution of xylazine in the body, physical symptoms, and factors predictive of chronic use was known: frequency of use depended on social or economic factors, as well as each user's subjective response to the drug's addictive properties. From November 2021 until August 2022, 80% of drug paraphernalia which tested positive for fentanyl at needle exchange programs in Maryland also contained xylazine. As of 2022, xylazine was almost invariably combined with opioids when used recreationally, and the drug produced a characteristic withdrawal syndrome which complicates treatment of addicted users. In April 2023, the Biden administration declared xylazine-laced fentanyl an official emerging drug threat to the nation, the first time such a label has been given. In 2022, the Drug Enforcement Administration (DEA) reported that 23% of seized fentanyl powder and 7% of fentanyl pills were found to have been adulterated with xylazine. In July 2023, the first death following xylazine use outside of North America was reported to have taken place in Solihull, England on May 22. A 43-year-old male was found dead at home with postmortem toxicology detecting heroin, cocaine, fentanyl and xylazine.
Lately Intelligence Officer, Home Office. For services to Border Security. The Reverend Christopher Richard Colledge. For services to the community in Bournemouth, Dorset. Alan Collier. Director, Procurement and Sustainability, Norfolk County Council. For services to Local Government. Dr. Michael Patrick Collins. Lately Science Lead on EU and International Science Partnerships, Department for Environment, Food and Rural Affairs. For services to International Science Policy. Denise Cooke. Administrative Officer, Maritime and Coastguard Agency. For Public Service. Laura Coryton. Tampon Tax Campaigner, Author and Co-Founder, Sex Ed Matters. For services to Charitable Campaigning. Margaret Irene Cosin. Lately Member, Dover District Council. For Political and Public Service. Stuart Samuel Cossar. Investigation Manager, Police Service of Scotland. For services to the Investigation and to the Bereaved Families of the Lockerbie Air Disaster. Anne Marie Coulter. Volunteer, Summerhill Community Centre. For services to the community in Dumfries. Samuel Robert John Cousley. Head of Seafarers, Department for Transport. For services to Seafarers. Professor Rachel Elizabeth Cowgill. Professor of Music, University of York. For services to Culture, to Education and to the Arts. John Hubert Cox. Chair, Joseph Cox Charity. For services to Homeless People in Manchester. Maureen Joan Cox. For charitable services in the London Borough of Hackney. Vanessa Sara Crocker. Co-Founder, Spread a Smile. For services to Seriously and Terminally Ill Children and their Families. Daniel Steven Paul Croft.
=== Precision Medicine === The protease modulatory web represents opportunities to identify novel biomarkers for disease and targets for drug design. Proteolytic processed N-termini have been proposed as potential biomarkers as disease specific proteolysis has been well studied in pathologies such as inflammation and cancer. Contributions to degradomics have identified numerous characterized and novel protease substrates and continue to lead to speculation of previously unknown protease targets. More recently, proteolytic signatures of cell death have been found using N-terminomic techniques on chemotherapy patient plasma samples. Advancements in SRM and MRM clinical assays also allow for analyzing proteolytic signature biomarkers in patient samples and can be complemented by PSP quantification. Deciphering these networks will aid drug design in understanding which substrates perform useful roles versus harmful ones to determine which should be targeted by drugs.
Sources: en.wikipedia.org
=== Italy === The Italian Armed Forces use the "Razione Viveri Speciali da Combattimento", consisting of a heavy duty brownish-green plastic bag with three thin white cardboard cartons inside (one for breakfast, one for lunch and one for dinner), each containing meal items plus accessories. There are seven menus, called "modules", identified by colors: yellow, red, grey, green, white, pink and blue. Typically, breakfast consists of: a chocolate bar, fruit candy, crackers or sweet bread, instant coffee, sugar, and a tube of sweetened condensed milk. Lunch has: two pull-ring cans with precooked foods (Tortellini al Ragù, Pasta e Fagioli, Wurstel, Tacchino in Gelatina, Insalata di Riso, etc.), a small can of fruit cocktail, a multivitamin tablet, energy and fiber tablets, instant coffee, sugar, and a plastic spoon wrapped with a napkin. Dinner consists of two more meal cans plus crackers, an energy bar, instant coffee, and sugar. Accessories are: a folding stove, fuel tablets, water purification tablets, toothpick, matches, and three small disposable toothbrushes with pre-applied tooth powder.
In November, Carrington destroyed villages adjacent to his line of communication and advanced towards Morija. In early December, he set up camp at Tsita's Nek, engaging in multiple clashes with the Basuto on the road to Morija. On 14 January 1881, Colonel Brabant led a force of 380 cavalry, 180 infantry, 400 armed burghers, and two 7-pounder guns towards Thaba Tsueu. Brabant sent the burghers ahead to capture the Radiamari village. After burning Radiamari, the burghers disregarded their orders and pushed further into Sepechele village, which was held by 8,000 men under Lerotholi. Chief Maama charged the burghers with 3,000 of his warriors, and the latter began to withdraw towards the rest of the Cape force. The Basuto managed to close in on the burghers but were eventually beaten off with carbine and artillery fire. As Maama retired, Lerotholi's warriors opened heavy fire from the surrounding ridges. Surgeon John Frederick McCrea of the 1st CMY won the Victoria Cross for attending injured burghers while being wounded himself. Brabant sent 140 riders from the Yeomanry in pursuit of Maama. The initial counter-attack failed after it was outflanked from the right. The Cape troops then dismounted and cleared the plateau and surrounding ridges. The Basuto suffered heavy casualties, while the Cape lost 16 killed and 21 wounded. Brabant then returned to his camp at Tsita's Nek. For most of the war the Cape's troops and administration remained isolated in the Hlotse, Maseru, and Mafeteng Districts. The lack of offensive action reduced the Cape troops' morale still further.
In her 2008 book The How of Happiness, Sonja Lyubomirsky similarly argued people's happiness varies around a genetic set point. Diener warns, however, that it is nonsensical to claim that "happiness is influenced 30–50% by genetics". Diener explains that the recipe for happiness for an individual always requires genetics, environment, and behaviour too, so it is nonsensical to claim that an individual's happiness is due to only one ingredient. Only differences in happiness can be attributed to differences in factors. In other words, Lyubomirsky's research does not discuss happiness in one individual; it discusses differences in happiness between two or more people. Specifically, Lyubomirsky suggests that 30–40% of the difference in happiness levels is due to genetics (i.e. heritable). In other words, still, Diener says it makes no sense to say one person's happiness is "due 50% to genetics", but it does make sense to say one person's difference in happiness is 50% due to differences in their genetics (and the rest is due to behaviour and environment). Findings from twin studies support the findings just mentioned. Twins reared apart had nearly the same levels of happiness thereby suggesting the environment is not entirely responsible for differences in people's happiness. Importantly, an individual's baseline happiness is not entirely determined by genetics, and not even by early life influences on one's genetics.
Sources: en.wikipedia.org
Vladimir Khavinson and colleagues at research institutes in Saint Petersburg developed and studied the peptide. Their program examined short peptides as regulators of aging and neuroendocrine function. Epitalon was one of several compounds produced by that group.
That question is not settled. Cell culture studies have reported increased telomerase activity after treatment, but comparable evidence from controlled human trials is lacking. Any claim about telomere lengthening in people should be treated as unproven.
It has not completed the large, controlled trials required for drug approval in major jurisdictions. Most human reports involve small samples and limited follow-up. As a result, it is sold as a research chemical rather than a licensed pharmaceutical product.
Mass spectrometry provides the identity check, because the observed mass is compared with the theoretical mass of the AEDG sequence. Chromatography separates and quantifies impurities but does not by itself prove which peptide is present. The two techniques are normally used together.